ERBB2 and gastric cancer: HER2 testing guidelines exist only for tumor types with approved HER2‐targeted therapies (i.e., breast and gastric cancers),9, 10 but other solid tumors also exhibit perturbations in HER2 protein and ERBB2 gene levels.